Quchang Ouyang

Hunan Cancer Hospital

Changsha, 410013

China

SCHOLARLY PAPERS

2

DOWNLOADS

46

CITATIONS

0

Scholarly Papers (2)

1.

Pyrotinib or Lapatinib Combined with Capecitabine in Women with HER2-Positive Metastatic Breast Cancer Previously Treated with Taxanes, Anthracyclines, And/Or Trastuzumab: An Open-Label, Randomised, Phase 2 Study

Number of pages: 111 Posted: 22 Nov 2018
Chinese Academy of Medical Sciences - Cancer Hospital, Hunan Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital, Department of Medical OncologyChinese Academy of Medical Sciences - Peking Union Medical College, Jilin University (JLU), Faculty of Medical Sciences, First Affiliated Hospital, Academy of Military Medical Science, Tianjin Medical University, Hebei Medical University, Peking University - Cancer Hospital and Institute, Huazhong University of Science and Technology (Formerly Tongi Medical University), Jiangsu Cancer Hospital - Department of Medical Oncology, Sun Yat-Sen University (SYSU) - Cancer Center, Fudan University - Shanghai Cancer Center (FUSCC), Jiangsu Hengrui Medicine Co., Ltd. and Jiangsu Hengrui Medicine Co., Ltd.
Downloads 32 (452,070)

Abstract:

Loading...

Pyrotinib, lapatinib, HER2-positive metastatic breast cancer

2.

Chidamide Plus Exemestane for Postmenopausal Patients with Hormone-Receptor-Positive Advanced Breast Cancer (ACE Study): A Randomised, Double-Blind, Placebo-Controlled Phase 3 Trial

Number of pages: 90 Posted: 05 Feb 2019
Chinese PLA General Hospital, Fifth Medical Centre, Jilin University (JLU), Faculty of Medical Sciences, First Affiliated Hospital, Fudan University - Shanghai Cancer Center (FUSCC), Harbin Medical University - Cancer Hospital, Liaoning Cancer Hospital & Institute, Henan Cancer Hospital, Sun Yat-Sen University (SYSU) - Cancer Center, Hunan Cancer Hospital, Jiangsu Province People's Hospital, Tumour Hospital of Hebei Province, Tianjin Medical University, Jilin Cancer Hospital, Anhui Provincial Hospital, Shandong University - Jinan Central Hospital, Third Hospital of Nanchang, Beijing Cancer Hospital, Anhui Medical University - First Affiliated Hospital, Jiangsu Cancer Hospital - Department of Medical Oncology, Zhejiang Cancer Hospital, Peking University - Shenzhen Hospital, Fudan University - Department of Medical Oncology, Cangzhou Central Hospital, Northwestern University - Feinberg School of Medicine, Chipscreen Biosciences Ltd and Chipscreen Biosciences Ltd
Downloads 14 (550,050)

Abstract:

Loading...

Chidamide; Histone deacetylase inhibitor; Exemestane; Hormonereceptor- positive; Advanced breast cancer; Phase 3 trial